Panaxia

Medical Cannabis Products

Startup

Panaxia is a Lod-based startup in the Health Tech & Life Sciences sector, established in 2009. Medical Cannabis Products. The company has raised a total of $11.6M across 3 funding rounds, currently at the Public stage. Panaxia was founded by Dadi Segal. Key investors include Undisclosed Investor(s), Eran Goldberg, Ran Nussbaum, among 7 total investors. The company has 51-200 employees. Core technologies: Materials & Substances, Raw Materials.

With $11.6M in total funding, Panaxia is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2C/B2B business model. Product stage: Released. The company holds 1 patent.

$11.6M
Raised
3
Rounds
7
Investors
4
Team
2009
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisMaterials & SubstancesRaw Materials
At a Glance
Investors

7 investors total

Founders
In the News

46 articles covered by sources including www.themarker.com, www.prnewswire.com, www.globes.co.il, www.sponser.co.il, en.globes.co.il.

www.themarker.com · Jan 29, 2024
עמוס לוזון נסוג - ופנאקסיה תימכר למייסד תמורת מחיקת החוב
Read article ↗
Frequently Asked Questions
What does Panaxia do?

Panaxia Pharmaceutical Industries specializes in the research, development, and manufacturing of medical cannabis. The company's goal is to align medical cannabis with formulation technologies and the highest available pharmaceutical standards. Panaxia currently manufactures a variety of standardized medical cannabis products including sublingual and oral tablets, metered-dose inhalers, creams, and suppositories. The company's products, manufacturing facility, and production processes are subject to stringent quality assurance procedures. Panaxia is part of the Panaxia Medical Devices and Pharmaceuticals Group. Panaxia's R&D center is located in Israel and is managed by senior scientists and graduates of the Weizmann Institute of Science. Panaxia offers more than 600 medical products in over 30 international markets to treat a wide range of symptoms and conditions.

How much funding has Panaxia raised?

Panaxia has raised $11.6M in total funding across 3 rounds. The company is currently at the Public stage. Key investors include Undisclosed Investor(s), Eran Goldberg, Ran Nussbaum.

Who founded Panaxia?

Panaxia was founded in 2009 by Dadi Segal (Co-founder & CEO).

What sector is Panaxia in?

Panaxia operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Medical Cannabis, with core technologies in Materials & Substances, Raw Materials. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.

Where is Panaxia located?

Panaxia is based in Bat Sheva St 1, Lod, Israel, Center District.

View Full Profile Classic View Website ↗